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Chitosan but Not Chitin Activates the Inflammasome by a
Mechanism Dependent upon Phagocytosis*
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Background: Chitin and its deacetylated derivative chitosan are abundant polysaccharides with poorly defined immuno-
logical properties.
Results: Chitosan, but not chitin, activates the NLRP3 inflammasome in a phagocytosis-dependent manner.
Conclusion: Acetylation of the chitosan polymer renders it incapable of activating the inflammasome.
Significance: Physicochemical properties of chitin and chitosan have been defined that determine whether an inflammatory
response takes place.
Chitin is an abundant polysaccharide found in fungal cell
walls, crustacean shells, and insect exoskeletons. The immuno-
logical properties of both chitin and its deacetylated derivative
chitosan are of relevance because of frequent natural exposure
and their use in medical applications. Depending on the prepa-
ration studied and the end point measured, these compounds
have been reported to induce allergic responses, inflammatory
responses, or no response at all. We prepared highly purified
chitosan and chitin and examined the capacity of these glycans
to stimulatemurinemacrophages to release the inflammasome-
associated cytokine IL-1.We found that although chitosanwas
a potent NLRP3 inflammasome activator, acetylation of the chi-
tosan to chitin resulted in a near total loss of activity. The size of
the chitosan particles played an important role, with small par-
ticles eliciting the greatest activity. An inverse relationship
between size and stimulatory activity was demonstrated using
chitosan passed through size exclusion filters as well as with
chitosan-coated beads of defined size. Partial digestion of chi-
tosan with pepsin resulted in a larger fraction of small phagocy-
tosable particles and more potent inflammasome activity. Inhi-
bition of phagocytosis with cytochalasin D abolished the IL-1
stimulatory activity of chitosan, offering an explanation for why
the largest particles were nearly devoid of activity. Thus, the
deacetylated polysaccharide chitosan potently activates the
NLRP3 inflammasome in a phagocytosis-dependentmanner. In
contrast, chitin is relatively inert.
Chitin, a -(1,4)-linked polymer of GlcNAc and its deacety-
lated derivative chitosan, a -(1,4)-linked polymer of glucos-
amine (GlcN),2 are two predominant, naturally occurring poly-
saccharides. Although not present in vertebrates, chitin, as a
major component in crustacean shells and insect exoskeletons,
is the second most abundant natural polysaccharide after cel-
lulose (1–3). It is also an essential component of fungal cell walls
and some parasites, including helminths and protozoa (4–7).
Chitosan is not as prevalent naturally, although somemedically
important fungi, particularly Cryptococcus neoformans and
members of the Zygomycetes, contain chitin deacetylases that
promote conversion of chitin to chitosan (8, 9). Exposure to
these polysaccharides also occurs as a result of their use in a
wide variety of pharmaceutical and commercial applications
(10–12).
Most commercial preparations of chitin and chitosan are
derived from crustacean shells. In addition to putative contam-
inants, these polymers are unlikely to be homogeneous. Meth-
ods to isolate and purify chitin generally result in partial
deacetylation of the polymer, whereas some acetylation
remains following the heat-alkali treatment used typically (13).
Thus, most marketed chitin and chitosan consist of both acety-
lated (GlcNAc) and deacetylated (GlcN) residues. Generally, a
polymer that is at least 60% deacetylated and soluble in weak
acid is considered to be chitosan (13). Chitin is insoluble in both
acid and base.
Despite the prevalence of chitin and chitosan, their immuno-
stimulatory properties are poorly understood. Varying reports
have characterized these polysaccharides as relatively inert,
proinflammatory, and proallergenic (14–18). Possible explana-
tions for these disparate findings include different sources (e.g.
shrimp, crab, fungal) and manufacturing processes utilized to
make the glycans, resulting in variability in the tertiary struc-
ture of the polymers and in the degree of contaminants (13, 19).
Chitin is frequently isolated from crustacean waste products
and is naturally associated with protein and minerals that are
difficult to remove. Purification by deproteinization followed
by demineralization will likely destroy the native structure (13).
Another possible explanation for the varied immunological
response is particle size. The importance of size has been sug-
gested by studies demonstrating differential stimulation of
TNF and IL-10 by size-fractionated chitin. Particles of inter-
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mediate size (40–70 m) induced just TNF, whereas smaller
particles (40 m) induced both TNF and IL-10 (20).
The inflammasome is a cytosolic complex containing, in
most cases, a Nod-like receptor (NLR), the adaptor molecule:
apoptosis-associated speck-like protein containing a card
(ASC) and caspase-1 (21). It is responsible for the processing
and release of IL-1, IL-18, and IL-33. Inflammasome activa-
tion involves a two-signal process, with the first signal generally
provided by a Toll-like receptor agonist, such as LPS, inducing
up-regulation of pro-IL-1. The second signal cleaves inactive
pro-caspase-1 to active caspase-1 in the inflammasome com-
plex, activating the complex to process and release mature
IL-1, IL-18, and IL-33 (22, 23). A wide variety of stimuli has
been shown to activate the inflammasome, including particu-
lates such as alum, chitosan, uric acid crystals, and silica (24–
27), cytosolic DNA (28), ATP (29), and the pore-forming toxin
nigericin (30). TheNLRP3 (NLR family, pyrin domain-contain-
ing 3) inflammasome is the most well studied of the inflam-
masomes and also the one with the most known activators.
In this study, we subjected chitin and chitosan to vigorous
purification and size fractionation procedures.We then studied
the immunological activity of the resulting preparations using
inflammasome activation as the readout. We found that chi-
tosan, but not chitin, is a potent NLRP3 inflammasome activa-
tor. Moreover, phagocytosis of the particles is necessary for
inflammasome activation.
EXPERIMENTAL PROCEDURES
Reagents andCell Culture—Allmaterials were obtained from
Sigma-Aldrich unless otherwise stated. Ultrapure LPS (free of
TLR2-stimulating lipopeptides) was purified from the original
Sigma stock (L2630) by two treatments with deoxycholate fol-
lowed by phenol extraction and ethanol precipitation (31). Chi-
tosan (76% deacetylated) was obtained fromPrimex. Chitin and
chitosan hexamers were purchased from Associates of Cape
Cod and used at a final concentration of 0.1 mg/ml. Complete
media is defined as RPMI 1640 media (Invitrogen) supple-
mented with 10% heat-inactivated FBS (Tissue Culture Biolog-
icals), 2 mM L-glutamine (Invitrogen), 100 units/ml penicillin,
and 100 g/ml streptomycin. Cell culture was performed at
37 °C in humidified air supplemented with 5% CO2. All exper-
iments were performed under conditions designed tominimize
endotoxin contamination.
Bone Marrow-derived Macrophages—Bone marrow-derived
macrophages (BMM) were generated as described (32).
Briefly, bone marrow was extracted from the femurs and tibiae
of WT C57BL/6 mice (The Jackson Laboratory) or NLRP3/
mice (33) (originally from Millennium Pharmaceuticals and
supplied to us by Dr. Katherine Fitzgerald, University of Mas-
sachusetts Medical School). Cells were cultured in complete
media supplemented with supernatant frommacrophage colo-
ny-stimulating factor-secreting L929 fibroblasts at a final con-
centration of 20% and fed on days 4 and 7 with fresh media
containing macrophage colony-stimulating factor. On day 8,
macrophages were treated with 0.05% trypsin-EDTA, har-
vested, and washed once in complete media before use in
experiments.
Chitosan Purification and Conversion to Chitin—Chitosan
was suspended (6 g/80 ml) in 1.0 M sodium hydroxide and
heated at 90 °C for 1 h. The chitosan was collected by centrifu-
gation and washed with PBS until the pH was neutralized. Half
of the purified chitosanwas converted to chitin by suspending it
in 20 ml of 1.0 M sodium bicarbonate followed by addition of 1
ml 97% acetic anhydride (Acros). The acetylation reaction was
performed at 22 °C for 20min with periodic mixing. The acety-
lated glycan was collected by centrifugation and further acety-
lated by suspension in fresh sodium bicarbonate and acetic
anhydride (as described above) for 20 min at 22 °C followed by
10min at 100 °C. The particles were collected by centrifugation
and washed three times with PBS. Both the chitin and chitosan
preparations were then passed through a 100-m nylon mesh
filter basket (BD Falcon) to remove the largest particles. The
preparations were further treated in 0.1 M sodium hydroxide at
22 °C for 30 min as a final purification procedure, followed by
washing twice with PBS. Samples were stored at 4 °C in PBS.
Determination of the Degree of Glycan Acetylation—Reacety-
lated chitosan was digested to monosaccharides with chitinase
followed by their separation using TLC. To 1 mg of chitin sus-
pended in 200 l of MacIlvaine’s citrate phosphate buffer (pH
6.0) were added 10l ofTrichoderma viride chitinase (5mg/ml
in PBS). Following incubation at 30 °C for 5 days, samples and
standards (5 l) were spotted on a silica gel 60 glass-backed
plate (EMD Chemicals) and developed using n-butanol:etha-
nol:water:acetic acid (5:4:3:1). Standards were GlcNAc and
GlcN at various concentrations ranging from 1–20 mM. Plates
were sprayed with 30% (w/v) ammonium hydrogen sulfate
(Acros Organics) in water and then baked at 140 °C for 30 min.
The spraying and baking were repeated two more times (34).
Visualizing the separated sugars was done with epi-UV illumi-
nation and a FluorChem HD2 digital imaging system (Alpha
Innotech). Quantifications of the digital images were done with
ImageJ.
Stimulation of IL-1—BMMwere plated 1 105 cells/well
in a 96-well plate. Cells were primed with 100 ng/ml ultrapure
LPS for 3 h (control cells were left unprimed), followed by incu-
bation with the stimuli for 1–6 h. Stimuli controls were alum
(Imject), synthetic double-stranded DNA: poly(dA:dT), and
nigericin. Supernatants were collected for cytokine measure-
ment, assayed by IL-1 ELISA (eBiosciences). Cytochalasin D
(1 mg/ml stock solution dissolved in chloroform) was added 30
min prior to stimuli addition for the phagocytosis inhibition
assays and utilized at a final concentration of 1 g/ml.
Immunoblot Analysis—BMM were plated at 1.5  106
cells/well in a 12-well plate. Cells were primed with 200 ng/ml
LPS for 3 h, followed by incubation with the indicated stimuli
for 6 h. Supernatants were collected and proteins precipitated
by methanol-chloroform extraction as described (35). Immu-
noblot analysis was performed as described (35) using anti-
mouse caspase-1 (clone 5B10, eBioscience) and anti-mouse
IL-1 (AF-401-NA, R&D Systems).
Chitosan Digestion—Chitosan (250 mg) was dissolved by
rotating overnight at 37 °C in 25 ml 0.1 M sodium acetate (pH
4.5). Pepsin (Sigma, P7000) was added to a final concentration
of 100 units/ml followed by rotating the sample at 37 °C for
18 h. Five ml 24:1 (v/v) chloroform:isoamyl alcohol were added
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and mixed by vortexing for 30 s. The phases were separated by
centrifugation, and 20 ml of the aqueous layer were removed.
Next, 20 ml 12% potassium hydroxide were added, which pre-
cipitated the chitosan, and the samplewas heated at 80 °C for 90
min. The digested, insoluble chitosan was washed three times
with 40 ml of water followed by PBS and stored at 4 °C.
Soluble Chitosan—Chitosan that had been digested with
pepsin as above was dissolved in 10 mM acetic acid (2 mg/ml)
and then diluted 1:100 in complete media and immediately
added to cells at a final concentration of 0.01 mg/ml. Undis-
solved (insoluble) chitosan was used as a control.
Size Fractionation—Chitosan and chitin particles in PBS
were subjected to three rounds of sonication using a microtip
probe at 30%power for 5min in PBS. Particles were first filtered
through a 100-m nylon mesh basket filter (BD Falcon). Parti-
cles that did not pass through that filter were collected for the
100 m fraction. The filtrate was then further fractionated
through a 20-m nylon mesh filter (Millipore) to create the
20 m fraction. Particles retained on the filter were collected
and designated the 20- to 100-m fraction. Uncoated, chitin-
coated, and chitosan-coated polystyrene beads with diameters
of 3 m and 50 m were from Micromod and New England
Biolabs. The chitosan beads were converted to chitin beads
with acetic anhydride. Briefly, the beads were washed sequen-
tially with water:methanol; first with 70:30 (v/v), then 50:50,
then 30:70, and finally 0:100. An equal volume of acetic anhy-
dride:methanol (50:50, v/v) was added to the beads followed by
rocking for 2 h at 22 °C. The beadswerewashed in reverse order
with the water:methanol mixtures and finally five times with
water. All beads were stored at 4 °C.
Sonication—Where indicated, chitin and chitosan prepara-
tions were suspended in 200 l PBS at a concentration of 10
mg/ml in 1.5-ml microcentrifuge tubes. The tubes were then
sonicated for 5 min using a horn sonicator (S-4000, Misonix,
Inc.) at 20% amplitude.
Statistical Analysis—Data were analyzed using GraphPad
Prism. Significancewas assessed by either two-way-ANOVAor
two-tailed unpaired t test as indicated. p values of 0.05 after
the Bonferroni correction were considered significant.
RESULTS
Chitin and Chitosan Purification—Chitosan was suspended
in 1.0 MNaOHat 90 °C for 1 h to remove possible contaminants
(Fig. 1A). In particular, NaOH destroys bacterial endotoxin
while having no effect on the chitosan polymer itself (13, 36).
After this purification step, half the chitosan sample was sus-
pended in 1M sodiumbicarbonate and acetic anhydride to acet-
ylate the chitosan to chitin (9), resulting in preparations that
only differ in their degree of acetylation. Both glycan prepara-
tions were then incubated with NaOH (0.1 M) to destroy any
endotoxin that might have been introduced during the conver-
sion or handling processes and to remove any O-acetyl groups
added during acetylation. To analyze the efficiency of the acety-
lation reaction, the chitin was digested with chitinase followed
by separation of GlcNAc andGlcN byTLC (Fig. 1B). The acety-
lation proved successful, with only about 7% of the residues
remaining deacetylated.
Chitosan Stimulates the Inflammasome and Chitin Does Not—
Mouse BMM were primed for 3 h with 100 ng/ml ultrapure
LPS and then stimulated with the pure chitosan and chitin
preparations generated as in Fig. 1A. Supernatantswere assayed
for IL-1 as ameasure of inflammasome activation.As reported
previously (27), chitosan stimulated IL-1 (Fig. 2A). However,
surprisingly, macrophages released only scant amounts of
IL-1 when stimulated with chitin. IL-1 stimulation by chi-
tosanwas dose-dependent, with peak stimulation seen at a con-
centration of 0.3 mg/ml (Fig. 2B). Inflammasome activation by
chitosan was dependent upon the NLRP3 inflammasome as
IL-1 was not detected in supernatants of chitosan-stimulated
macrophages from NLRP3/mice (Fig. 2C). IL-1 release
from NLRP3-deficient macrophages was severely reduced in
response to alum, which is known to predominantly activate
this inflammasome, but remained intact in response to the
AIM2 inflammasome activator poly(dA:dT).
IL-1 Release Is Size-dependant—Next we examined the
influence of particle size on the capacity of chitin and chitosan
to stimulate IL-1. Accordingly, we sonicated the chitosan and
chitin preparations to generate smaller particles and then size-
fractionated the preparations by sequential passage through
100-m and 20-m filters. This resulted in fractions with pre-
dicted sizes of 20 m, 20–100 m, and 100 m. These
three fractions were then compared with the sonicated but
unfractionated polysaccharides for their ability to stimulate
IL-1 release from primed macrophages (Fig. 3A). Chitosan
induced the most IL-1 from the20 fraction, with the100
fraction eliciting only low amounts of IL-1. This suggests that
smaller chitosan particles are primarily responsible for induc-
ing IL-1. The low amount of activity in the100 fractionmay
have been due, at least in part, to the presence of some smaller
particles that were retained by the filter despite washing.
Although greatly reduced compared with chitosan and the
positive control alum, the sonicated preparations of chitin did
induce some IL-1. One possible explanation for this activity is
that sonication broke apart large particles of chitin that had
cores of chitosan that were inaccessible to the acetylation reac-
tion. Upon sonication, these particles were broken apart,
exposing their inner chitosan, which then was able to activate
IL-1. To address this and further study the influence of parti-
FIGURE1.ChitinandchitosanpurificationandTLCanalysis.A, commercial
chitosan was treated with 1 M sodium hydroxide. A portion of the chitosan
was then converted to chitin by suspension in sodium bicarbonate with ace-
tic anhydride to drive the acetylation reaction. Both preparations were then
further purified in 0.1 M sodium hydroxide. B, to assess the efficacy of the
acetylation reaction, the chitin was digested to monomers by T. viride chiti-
nase and analyzed by TLC.
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cle size, we used 3- and 50-m polystyrene beads that were
coatedwith chitin or chitosan. This provided a uniformparticle
size and glycan surface. Uncoated polystyrene beads served as
additional controls. Uncoated beads and chitin-coated beads
stimulated little IL-1 activity (Fig. 3B). However, the 3-m
beads coated with chitosan elicited a strong IL-1 response.
None of the 50-m beads, regardless of their surface, stimu-
lated macrophage IL-1 release. Both the chitin and chitosan
3-mbeads were readily phagocytosed bymacrophages (Fig. 3,
C andD), whereas the 50-mbeads were too large to be phago-
cytosed (data not shown). These data provide further support
for the concept that chitosan, but not chitin, potently stimu-
lates IL-1 via a size-dependent mechanism.
PepsinDigestion of Chitosan—As an alternative way to exam-
ine the effect of particle size, we took advantage of the ability of
pepsin to partially digest chitosan (37). Following the procedure
outlined in Fig. 4A, chitosan was digested with pepsin. Upon
digestion, the thick, viscous chitosan solution became much less
viscous, suggesting a successful digestion. After the digestion, the
chitosan was chloroform-extracted to remove the pepsin and
other possible contaminants. The chitosan was then precipitated,
and half was converted to chitin. Both glycans were then assayed
for their ability to activate the inflammasomebymeasuring release
of IL-1 activity (Fig. 4B). The digested chitosan was a potent
IL-1 activator, with peak activity again seen at 0.3 mg/ml. Once
again, chitin was nearly inert. Chitosan, but not chitin, stimulated
cleavage of pro-caspase-1 to active caspase-1 and pro-IL-1 to the
mature form of IL-1 (Fig. 4C).
Regardless of whether prepared as in Fig. 1A (NaOH) or Fig.
4A (pepsin), both chitin and chitosan particles aggregate when
left to stand over time, although the average size of the glycans
produced through the method used in Fig. 4A was smaller. We
next studied whether breaking up the aggregates with soni-
cation affected the ability of the glycans to stimulate the
inflammasome. Mild sonication in a horn sonicator did not
significantly affect IL-1 release in response to theNaOHprep-
arations, but there was a significant increase in IL-1 activity
after sonication of the pepsin-digested chitosan preparation
(Fig. 4D). Neither chitin preparation induced more IL-1 after
mild sonication.
We tested whether chitin’s inability to induce IL-1 was
because it does not activate the inflammasome or because it
actively suppresses the inflammasome (Fig. 4E). Macrophages
were preincubated with 0.1 mg/ml pepsin-digested chitin and
then stimulated with alum, chitosan or nigericin (an ionophore
which stimulates the inflammasome independently of phago-
cytosis (24)). We found that chitin was unable to inhibit IL-1
release by any of these stimuli.
Effect of Solubilizing the Chitosan—Wenext studied whether
soluble chitin and chitosan hexamers stimulate the inflam-
masome. However, after a 6-h stimulation of LPS-primed
BMM with chitin and chitosan hexamers, IL-1 concentra-
FIGURE 2. Inflammasome activation stimulated by chitin and chitosan.
A, BMM (1  105/well) were primed for 3 h with 100 ng/ml LPS or left
unprimed and then stimulated for 6 h with alum (0.1 mg/ml) or with the
chitosan and chitin (0.1 mg/ml) preparations generated as in Fig. 1. Superna-
tants were assayed for the inflammasome cytokine IL-1 by ELISA. Data are
means S.E. of four independent experiments, each performed in triplicate.
p  0.001 comparing primed chitin to primed chitosan, unprimed alum to
primedalum, andunprimed chitosan toprimed chitosan, as analyzedby two-
wayANOVA.B, dose response curveof chitin and chitosan stimulatingBMM
(1  105/well) after they were primed for 3 h with 100 ng/ml LPS. Data are
means S.E. of four independent experiments, each performed in triplicate.
C, IL-1 production from stimulated WT and NLRP3/ macrophages was
compared. Chitin and chitosan were used at 1 mg/ml. Alum (1 mg/ml) and
dAdT (2 g/ml), which stimulate the NLRP3 and AIM2 inflammasomes,
respectively, served as controls. IL-1 release was significantly reduced in
NLRP3/ macrophages stimulated with alum and chitosan. Data are
means S.E. of a representative of two independent experiments, each per-
formed in triplicate. p  0.001 comparing WT macrophages and NALP3/
macrophages stimulated by chitosan or alum as analyzed by two-way
ANOVA.
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tions in the supernatants were below the limits of detection. To
examine whether the lack of stimulation by the chitosan hex-
amerswas a general property of soluble chitosan, we solubilized
chitosan by dissolving it in dilute acetic acid. Although the sol-
uble chitosan induced IL-1 release, the levels were less than
20% of that seen when insoluble particulate chitosan served as
the stimulus (Fig. 4F).
Effect of Cytochalasin D on IL-1 Activation—The inverse
association of size of the chitosan particles with inflammasome
activity suggests that phagocytosis is necessary for inflam-
masome activation. To test this supposition further, we exam-
ined the effect of cytochalasin D, an inhibitor of actin polymer-
ization andphagocytosis, on stimulated release of IL-1 (Fig. 5).
For the particulates, alum and chitosan, pretreatment of
macrophages with cytochalasin D significantly reduced the
amount of IL-1 produced. The small amount of IL-1 stimu-
lated by the chitin was also inhibited by cytochalasin D. How-
ever, IL-1 production in response to soluble nigericin was
unaffected. Taken together, the data demonstrate that phago-
cytosis is required for IL-1 activation by chitosan.
DISCUSSION
The immunological properties of chitin and chitosan have
been the subject of much investigation. However, previously
reported studies generally used partially purified preparations
and/or did not compare the two glycans side by side. Here we
utilized preparations that were derived from a common source
and differed solely by their degree of acetylation to ascertain
what impact acetylation had on inflammasome activation. We
found that although chitosan potently activates the inflam-
masome, chitin is only a very weak stimulator.
The seemingly contradictory literature on the immunos-
timulatory properties of chitin and chitosan are likely due to
many factors, including differences in the sources of the mate-
rial, procedures used for purification, readouts for inflamma-
tory responses, and the size of the glycan particles. Most pub-
lished studies on chitin and chitosan used preparations derived
from crustacean sources (16, 20), as in our studies, although
some have used chitin isolated from fungi (19, 38). There are
known structural differences between the two sources (39) that
could have an impact on how the particles effect the immuno-
logical response. Chitin and chitosan are able to withstand
many harsh purification procedures (40). However, some of
these procedures may affect the tertiary structure of the poly-
mers (13). Additionally, methods of purification are often
proprietary, and endotoxin, glucans, proteins, and other
contaminants may impact the results obtained. We obtained
relatively pure chitosan and then undertook a series of fur-
ther purification steps. These steps included NaOH treat-
ment to destroy possible endotoxin contaminants (36) and
chloroform to extract remaining proteins. Finally, for each
experiment, half of the chitosan was acetylated to chitin, and
therefore one would expect that had contaminants remained
after the purification procedure, they would be present in
both of the preparations. With only the chitosan having sub-
stantial capacity for stimulating the inflammasome, the
activity is unlikely to be due to a contaminant but because of
the polysaccharide itself.
In addition to contaminants, disparities in the size of the
chitin and chitosan preparations may account for some of the
seemingly contradictory results reported in the literature. In a
prior study, particle size was reported to impact the capacity of
chitin to stimulate macrophage TNF and IL-10 production
(20). However, in our studies, chitin was a poor activator of the
inflammasome regardless of particle size. In contrast, size had a
FIGURE 3. The effect of particle size on inflammasome activation. A, chitosan and chitin preparations prepared as in Fig. 1 were sonicated and then
size-fractionated through 100-m and 20-m filters. BMM (1  105/well) were primed with LPS and then stimulated with chitosan or chitin particles (1
mg/ml) that were left unfractionated (unfract) or size-fractionated as indicated. IL-1 was analyzed by ELISA. Data are means  S.E. of three independent
experiments, each performed in triplicate. p 0.001 comparing unfractionated chitosan to 20–100 chitosan and100 chitosan fractions, and between the
20 chitosan fraction and the 20–100 and100 chitosan fractions, analyzed by two-way ANOVA. B, LPS-primed BMM (1 105/well) were left unstimulated
(Unstim) or incubated for 6 hwith the indicated size and type of beads (1mg/ml). Alum (1mg/ml) served as a positive control. Supernatants were analyzed for
IL-1 by ELISA. Data are means S.E. of three independent experiments, each performed in triplicate. p 0.01 comparing 3-m chitosan beads and 50-m
chitosan beads by two-way ANOVA. Shown are representative photomicrographs of BMM following 30-min incubation with 3-m chitin-coated (C) and
chitosan-coated (D) beads demonstrating robust phagocytosis of both types of glycan-coated beads.
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major influence on the immunostimulatory properties of
chitosan.
Several lines of evidence support the inverse relation
between size and the ability of chitosan to stimulate the inflam-
masome. First, when the particulate glycans were passed
through filters of defined size, the smallest size fraction (20
m) induced the most cleavage of pro-IL-1 and release of the
mature cytokine. The larger-sized fractions also had some bio-
FIGURE4.Effectofpepsindigestionofchitosanoninflammasomeactivation.Followingtheprocedureoutlined inA, chitosanwasdigestedwithpepsinandthen
half was converted to chitin. B, dose curve of the pepsin-treated chitin and chitosan-stimulating BMM (1 105/well) after theywere primed for 3 hwith 100 ng/ml
LPS.Data aremeans S.E. of four independent experiments, eachperformed in triplicate.p0.01 comparing chitin and chitosan at any concentration0.1mg/ml
as analyzed by unpaired t test. C, BMM (1.5 106/well) were primed for 3 hwith 100 ng/ml LPS and then stimulatedwith alum (0.1mg/ml) or chitin and chitosan
derived fromtheprocedureoutlined inFig. 4A (pepsin)or theprocedureoutlined inFig. 1A (NaOH). Supernatantswere thencollectedandanalyzed for caspase-1and
IL-1B by immunoblot. Caspase-1 p20 and IL-1B p17 represent themature forms and indicate an active inflammasome,whereas caspase-1 p45 is an inactive proform
ofcaspase-1.D, BMM (1105/well)wereprimedas inBandthenstimulatedwithalumorchitinandchitosanderived fromtheprocedureoutlined inFig.4A (pepsin)
or theprocedure outlined in Fig. 1A (NaOH). The chitin and chitosanpreparationswere left unsonicated (no sonication) or sonicated for 5min (5min). All stimuliwere
added at a concentration of 0.1mg/ml. Supernatantswere analyzed by ELISA for IL-1. Data aremeans S.E. of three independent experiments, each performed in
triplicate. p 0.001 comparing no sonication and 5-min sonication of pepsin chitosan by two-way ANOVA. E, BMM (1 105/well) were primed as in B. Two hours
later, wells either received 0.1mg/ml chitin orwere left without chitin treatment (no chitin). One hour later, cells were left unstimulated (unstim) or stimulated for 6 h
withalum(0.1mg/ml), or chitosan (0.1mg/ml), or 1hwithnigericin (2.5M). SupernatantswereanalyzedbyELISA for IL-1. DataaremeanS.E. of two independent
experiments, eachperformed in triplicate.F, BMM (1105/well)wereprimedas inB. Insoluble suspendedchitosanandchitosan thathadbeensolubilized inacetic
acidwerediluted inmediaandaddedtocells. SupernatantswereanalyzedbyELISAfor IL-1.DataaremeansS.E.of two independentexperiments,eachperformed
in triplicate. p 0.01 comparing insolublewith soluble chitosan by two-tailed unpaired t test.
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activity, whichmayhave beendue to some smaller particles that
failed to pass through the filters. Second, when macrophages
were challengedwith chitosan-coated beads, the 3-m- but not
the 50-m-diameter chitosan beads were stimulatory. Third,
partial digestion of chitosan with pepsin boosted the ability of
the glycan to activate the inflammasome. Finally, mild sonica-
tion, which broke up aggregated particles, resulted in a boost in
the IL-1 signal.
Generally, small particles or soluble compounds have been
found to be the best activators of the inflammasome, although
inflammasome stimulation following “frustrated phagocyto-
sis,” defined as the process whereby phagocytes attempt to
phagocytose particles too large to be ingested, has been
described (24). With chitosan though, inflammasome activa-
tion did not occur via frustrated phagocytosis, as the 50-m
chitosan-coated beads were not stimulatory. Rather, phagocy-
tosis appeared to be required for inflammasome activation, as
particles that were small enough to be phagocytosed were the
best activators. Moreover, treatment of macrophages with
cytochalasin D, which inhibits phagocytosis, abolished chi-
tosan-induced IL-1 release. Similarly, for other particulate
activators of the inflammasome, inhibition of phagocytosis also
abrogates inflammasome activation (24, 41).
In addition to a requirement that chitosan particles be small
enough to be phagocytosed, optimal inflammasome stimula-
tion required that the chitosan be in a particulate form. Soluble
chitosan hexamers failed to stimulate IL-1 release, whereas
soluble chitosan stimulated greatly reduced amounts of IL-1
compared with particulate chitosan. An analogous situation
exists for -D-glucans where Dectin 1 signaling and cytokine
release is activated by particulate, but not soluble, -glucans
(42). Taken together, these data emphasize that the level of
stimulation seen with glycans will vary as a function of their
physicochemical properties, including size, solubility, and ter-
tiary structure.
The inflammasome is an important component of the
immune response to fungal infections. IL-1 has been shown to
be essential for host defenses against fungal pathogens (43), and
several fungal pathogens have been shown to activate the
NLRP3 inflammasome (44–46). Our data suggest that cell wall
chitin is unlikely to contribute greatly to the IL-1 release seen
in response to fungal stimulation. A more likely stimulator is
-glucans, which are abundant components of the fungal cell
wall and have recently been shown to be activators of the
NLRP3 inflammasome (46). Although a mutant strain of Can-
dida albicanswith reduced chitin content stimulated less IL-1
release comparedwith thewild-type parent (47), compensatory
structural changes in the cell wall could have been responsible
for the results. However, for those fungi such as C. neoformans,
that contain significant amounts of chitosan that glycan could
contribute to inflammasome activation. Although chitin and
chitosan are part of the inner cell wall and therefore not sur-
face-exposed, following phagocytosis and phagolysosomal
fusion, digestion by lysozyme and chitinase could result in
release of fragments of chitin and chitosan.
Chitosan has been demonstrated to have adjuvant proper-
ties, leading some to propose its use as a vaccine adjuvant (48–
52). If future studies determine that the adjuvant properties of
chitosan are inflammasome-dependent, then formulations
consisting of particles small enough to be phagocytosed would
likely lead to maximum effectiveness. Interestingly, the com-
monly used adjuvant alum also stimulates the NLRP3 inflam-
masome (27, 53, 54), although recent studies have suggested
that the ability of alum to activate the inflammasome is not
required for its adjuvanticity (55). Chitosan has also been
utilized to encapsulate DNA (56), and the primary amines of
chitosan can be exploited to conjugate antigens, thus allow-
ing direct delivery into cells. Conversely, in biomedical
applications where inflammatory responses are not desired,
such as in bioprostheses, our data suggest that non-phago-
cytosable (e.g.  50 m) chitosan and/or acetylation to chi-
tin should be considered.
The mechanistic basis for why chitosan activates the
inflammasome but chitin does not is speculative. Chitin does
not play an inhibitory role, as incubation of macrophages
with chitin does not prevent IL-1 release by known activa-
tors of the inflammasome. Although chitosan is charged
because of its free amine, the presence of N-acetylation
results in chitin lacking charge. Thus, activation could be
dependent, at least in part, on a charge-charge interaction,
although a large variety of compounds activate the NLRP3
inflammasome, including -glucan, which is uncharged (46).
Another possible explanation for inflammasome activation
by chitosan but not chitin may be related to differences that
occur in the phagolysosome after uptake. Although chitin
and chitosan particles are readily phagocytosed, the environ-
ment of the phagolysosome is likely to have very different
effects on the two glycans. Acid-soluble chitosan may
become soluble in the phagolysosome, whereas chitin will
remain particulate. Conversely, mammalian white blood
cells contain chitinases and lysozyme (3, 57) that can act on
both chitosan and chitin but are more effective on chitin (58,
59). These properties may better enable chitosan to translo-
cate from the phagolysosome to the cytosolic compartment
and activate the NLRP3 inflammasome.
FIGURE 5. Inhibition of phagocytosis blocks inflammasome activation.
BMM (1  105/well) were primed for 3 h with 100 ng/ml LPS. The BMM
were treatedwith 1g/ml cytochalasinD to inhibit phagocytosis 10minprior
to addition of stimuli. After 1 h stimulation with nigericin (2.5M), or 6 h with
alum (0.1 mg/ml), chitin (0.1 mg/ml), and chitosan (0.1 mg/ml), supernatants
were collected and analyzed by ELISA. Data are means S.E. of three exper-
iments performed in triplicate. p 0.001 comparing cytokine concentrations
with and without cytochalasin D following stimulation with alum and chi-
tosan, analyzed by two-tailed unpaired t test.
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In summary, we have demonstrated that chitosan potently
activates the inflammasome, whereas chitin does not. More-
over, stimulation of IL-1 release by chitosan is dependent on
both phagocytosis and assembly of the NLRP3 inflammasome.
It is possible that the inflammasome response elicited by expo-
sure to naturally occurring versions of these glycans may vary
because of the variable degrees of acetylation found in natural
chitin and chitosan. However, our findings have important
implications for the formulation of chitin and chitosan for use
in biomedical applications, both in situations where an inflam-
matory response is desirable (e.g. enhancing adjuvanticity) and
in those where it is not (e.g. bioprostheses). Finally, our
improved methodology for purification of chitin and chitosan
will be useful to those studying or preparing these ubiquitous
glycans.
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